Polynucleotides encoding an actriib antibody

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9403910
APP PUB NO 20130189269A1
SERIAL NO

13828419

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ACCELERON PHARMA INC.;DYAX CORP.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buckler, David Chester, US 23 311
Cosic, Janja Arlington, US 8 62
Davies, Monique Harpswell, US 8 69
Grinberg, Asya Lexington, US 115 365
Kent, Rachel Boxborough, US 7 57
Kumar, Ravindra Acton, US 237 2915
Martik, Diana Cambridge, US 7 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 2, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00